Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betadine for prevention of lymphocele after kidney transplantation
IRCT20240213060999N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of povidone-iodine in lymphocele (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Lymphocele. Started Apr 2024; status: completed.
02
Drugs
povidone-iodine
03
Conditions
lymphocele
Beyond the preview
Go deeper on IRCT20240213060999N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240213060999N1.